Longboard Pharmaceuticals has reported an EPS of $(2.39) for the fiscal year 2023, which marks an improvement from $(2.56) year over year. Throughout the year, the company has shared various corporate updates, highlighting important milestones and financial results. In the third quarter of 2023, Longboard Pharmaceuticals continued to make progress, with a focus on key studies such as the LP352 Phase 1b/2a PACIFIC Study. As of the end of the second quarter of 2023, the company had $63.0 million in cash, cash equivalents, and investments, which will support operations until mid-2024. The balance sheet reflects current assets, including cash, cash equivalents, and short-term investments. Longboard Pharmaceuticals remains committed to its research and development efforts, operational plans, and financial position in order to advance its programs successfully. For more detailed information on Longboard Pharmaceuticals’ corporate updates and financial performance, please refer to the latest reports.
KKR Stock Soars on March 12, 2024, Trading Near 52-Week Highs
On March 12, 2024, KKR stock had a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The stock closed at $99.18, representing a $1.79 increase since the market last closed, a 1.84% rise. In after-hours trading, KKR stock dropped $0.18. Despite this slight decrease, the overall performance of the stock on March 12 was positive, showing strong momentum and investor confidence in the company.
KKR & Co. Inc. (KKR) Stock Shows Impressive Financial Performance in Latest Report
On March 12, 2024, KKR & Co. Inc. (KKR) stock showed impressive performance based on the latest financial data provided by CNN Money. The company reported total revenue of $16.45 billion for the past year, representing a significant increase of 210.96% compared to the previous year. In the fourth quarter alone, KKR generated $6.34 billion in total revenue, marking a 106.43% increase from the previous quarter.
KKR reported a net income of $3.73 billion for the past year, reflecting a remarkable growth of 543.72% from the previous year. However, the net income remained flat at $1.04 billion in the fourth quarter compared to the previous quarter.
Earnings per share (EPS) for KKR stood at $4.09 for the past year, showing a substantial increase of 437.1% from the previous year. Despite the strong performance in EPS for the year, it remained unchanged at $1.14 in the fourth quarter compared to the previous quarter.
Overall, KKR stock demonstrated robust financial performance with significant growth in total revenue and net income over the past year. The company’s strong earnings per share also indicate positive growth potential for investors. Investors may view KKR as a promising investment opportunity based on its solid financial performance and growth prospects.
